Sirromax Ltd
Business Coaches
Sirromax Ltd
71-75 Shelton St, London
# Sirromax Ltd
Sirromax is a London-based health economics and market access consultancy with over 30 years of industry experience. They help pharmaceutical and medical device companies navigate complex regulatory pathways, secure reimbursement, and optimise market entry strategies across global markets.
The firm serves pharmaceutical manufacturers, medical device companies, and healthcare organisations seeking to commercialise products effectively. They specialise particularly in ophthalmic pharmaceuticals and devices, though their expertise extends across broader healthcare sectors.
What distinguishes Sirromax is their integrated approach combining strategic market access consulting with rigorous health economics analysis. Rather than offering isolated services, they provide end-to-end support—from initial market assessment and reimbursement strategy through to field-based implementation and stakeholder engagement. Their team conducts sophisticated health technology appraisals, real-world evidence studies, and economic modelling whilst simultaneously developing compelling value narratives and managing payer negotiations.
The consultancy bridges the gap between academic evidence and commercial reality. They don't simply produce reports; they coach internal teams, develop negotiation capabilities, and provide on-ground support to ensure strategies translate into tangible market outcomes. Their advisory board facilitation and key opinion leader engagement reflect deep healthcare systems knowledge across multiple jurisdictions.
For companies facing reimbursement hurdles, pricing pressures, or market access obstacles, Sirromax offers strategic clarity backed by rigorous analysis and practical implementation experience. Their longevity in the sector signals trusted relationships and proven results within the industry.
Sirromax is a London-based health economics and market access consultancy with over 30 years of industry experience. They help pharmaceutical and medical device companies navigate complex regulatory pathways, secure reimbursement, and optimise market entry strategies across global markets.
The firm serves pharmaceutical manufacturers, medical device companies, and healthcare organisations seeking to commercialise products effectively. They specialise particularly in ophthalmic pharmaceuticals and devices, though their expertise extends across broader healthcare sectors.
What distinguishes Sirromax is their integrated approach combining strategic market access consulting with rigorous health economics analysis. Rather than offering isolated services, they provide end-to-end support—from initial market assessment and reimbursement strategy through to field-based implementation and stakeholder engagement. Their team conducts sophisticated health technology appraisals, real-world evidence studies, and economic modelling whilst simultaneously developing compelling value narratives and managing payer negotiations.
The consultancy bridges the gap between academic evidence and commercial reality. They don't simply produce reports; they coach internal teams, develop negotiation capabilities, and provide on-ground support to ensure strategies translate into tangible market outcomes. Their advisory board facilitation and key opinion leader engagement reflect deep healthcare systems knowledge across multiple jurisdictions.
For companies facing reimbursement hurdles, pricing pressures, or market access obstacles, Sirromax offers strategic clarity backed by rigorous analysis and practical implementation experience. Their longevity in the sector signals trusted relationships and proven results within the industry.
Services offered
Market access pathway mappingHealth technology appraisal strategyEconomic modellingReal world evidence generationReimbursement applicationsPricing strategy and willingness-to-pay researchValue dossier developmentClinical trial design and regulatory strategy